beta blockers
Sponsors
MaineHealth, Hasselt University, Boehringer Ingelheim, Yanjing Gao, Tel-Aviv Sourasky Medical Center
Conditions
Atrial FibrillationAtrial FlutterCardiac FailureHFrEF - Heart Failure With Reduced Ejection FractionHeart DiseaseHeart DiseasesHeart FailureHeart Failure (HF)
Phase 3
Phase 4
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients
CompletedNCT02200822
Start: 2014-07-31End: 2019-02-28Updated: 2019-08-01
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
CompletedNCT04757584
Start: 2021-04-01End: 2023-04-28Updated: 2024-04-09
Impact of Beta-blockers on Physical Function in HFpEF
CompletedNCT04767061
Start: 2021-04-01End: 2023-04-28Updated: 2023-09-08
Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)
Enrolling by invitationNCT07252310
Start: 2026-02-10End: 2027-08-01Target: 5Updated: 2026-02-19
Unknown Phase
Effect of Caldine® on Renal Function in Balanced Hypertension
TerminatedNCT02240641
Start: 1998-05-31Updated: 2014-09-16
The Treatment of Hepatocirrhosis and Portal Hypertension
CompletedNCT02778425
Start: 2016-02-29End: 2020-01-31Updated: 2025-02-14
Evaluation and Management of Cardio Toxicity in Oncologic Patients
RecruitingNCT02818517
Start: 2016-08-01End: 2031-12-31Target: 1000Updated: 2022-02-02
Exploring Mechanisms and Morphology of QT Interval Prolongation
CompletedNCT03291145
Start: 2017-06-27End: 2019-01-01Updated: 2019-02-21